Feature Channels: Pharmaceuticals

Filters close
28-Mar-2023 7:40 PM EDT
Drug overdose fatalities among US older adults has quadrupled over 20 years, UCLA research finds
University of California, Los Angeles (UCLA), Health Sciences

Overdose mortality among people age 65 and older quadrupled over 20 years, suggesting the need for greater mental health and substance use disorder policies addressed at curbing the trend.

Released: 29-Mar-2023 9:50 AM EDT
FDA’s approval of over-the-counter naloxone will save lives
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) urges the public to help fight the opioid epidemic by learning to recognize and respond to an overdose. This includes understanding how to use naloxone, a life-saving medication approved today for sale over the counter by the U.S. Food and Drug Administration.

20-Mar-2023 11:45 PM EDT
ACS Spring 2023 Media Briefing Schedule
American Chemical Society (ACS)

Recordings of media briefings will be posted by 10 a.m. Eastern Time on each day. Watch recorded media briefings at: www.acs.org/ACSSpring2023briefings.

   
20-Mar-2023 9:00 AM EDT
Scientists see anti-aging potential in an invasive weed
American Society for Biochemistry and Molecular Biology (ASBMB)

The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research.

   
20-Mar-2023 9:00 AM EDT
New insights into an old drug: Scientists discover why aspirin works so well
American Society for Biochemistry and Molecular Biology (ASBMB)

New research has revealed important information about how aspirin works. The new findings could pave the way to safer aspirin alternatives and might also have implications for improving cancer immunotherapies.

Newswise: Sylvester Surgical Oncologist Awarded $375,000 NCI Grant to Investigate the Role Opioids May Play in Breast Cancer
Released: 28-Mar-2023 3:50 PM EDT
Sylvester Surgical Oncologist Awarded $375,000 NCI Grant to Investigate the Role Opioids May Play in Breast Cancer
Sylvester Comprehensive Cancer Center

Kristin Rojas, M.D., assistant professor of surgical oncology at Sylvester Comprehensive Cancer Center, has been awarded a three-year, $375,000 grant to investigate the role opioids may play in breast cancer.

Released: 28-Mar-2023 2:20 PM EDT
From the doctor's office to the operating room: Keep up with the latest in healthcare here
Newswise

From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.

Newswise:Video Embedded ornl-led-team-designs-molecule-to-disrupt-sars-cov-2-infection
VIDEO
Released: 28-Mar-2023 11:30 AM EDT
ORNL-led team designs molecule to disrupt SARS-CoV-2 infection
Oak Ridge National Laboratory

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

Newswise: Fibroblast Inhibitors Assist Anti-Cancer Drugs to Suppress Cancer Growth
24-Mar-2023 11:05 AM EDT
Fibroblast Inhibitors Assist Anti-Cancer Drugs to Suppress Cancer Growth
American Institute of Physics (AIP)

In APL Bioengineering, researchers develop a 3D cell culture system to test how inhibiting fibroblast activities can help treat lung cancer. To simulate the tumor microenvironment and mimic real tissues, the team co-cultured lung cancer cells and fibroblasts in a 3D matrix. The researchers then tested the anti-cancer drug cisplatin with and without two anti-fibrotic drugs, nintedanib and pirfenidone. They found that combining the anti-fibrotic drug nintedanib with the anti-cancer drug cisplatin increased the efficacy of the latter.

   
Newswise: Marijuana-derived compounds could reverse opioid overdoses
20-Mar-2023 11:45 PM EDT
Marijuana-derived compounds could reverse opioid overdoses
American Chemical Society (ACS)

Naloxone can reverse potentially fatal overdoses, but it’s less effective against powerful fentanyl. To develop alternatives, researchers are looking to a component of marijuana, CBD. They will present their results at ACS Spring 2023.

   
Released: 27-Mar-2023 1:00 PM EDT
Appellate Court Affirms Dismissal of Pacira’s Lawsuit Against ASA and Authors
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) is extremely pleased that the decision in the lawsuit filed against ASA, the editor-in-chief of Anesthesiology – the official peer-reviewed scientific journal of ASA – and 11 contributing authors by Pacira Biosciences Inc., which was originally dismissed by the United States District Court for the District of New Jersey in 2022, has been affirmed by the United States Court of Appeals for the Third Circuit.

Newswise: APS Upgrade to enhance ​‘molecular movies’ to understand certain types of antibiotic resistance
Released: 27-Mar-2023 10:05 AM EDT
APS Upgrade to enhance ​‘molecular movies’ to understand certain types of antibiotic resistance
Argonne National Laboratory

Researchers at Argonne’s Advanced Photon Source have used serial crystallography, a way to make molecular movies, to see in real time the mechanisms involved in an enzyme that confers antibiotic resistance to a certain bacterium.

Newswise: A puff of air could deliver your next vaccine (video)
20-Mar-2023 11:45 PM EDT
A puff of air could deliver your next vaccine (video)
American Chemical Society (ACS)

Needles are an uncomfortable but necessary aspect of vaccination. But today, scientists report steps toward an alternative, relatively painless method that can deliver biological materials to cells by “shooting” them in with air. They will present their results at ACS Spring 2023.

   
20-Mar-2023 9:00 AM EDT
Scientists make critical progress toward preventing C. diff infections
American Society for Biochemistry and Molecular Biology (ASBMB)

A new study identified a compound that prevents C. diff infection. Researchers are now using this compound to develop new drug candidates that might eventually offer a way to prevent serious C. diff infections.

Newswise: Tiny nanoparticle could have big impact on patients receiving corneal transplants
Released: 24-Mar-2023 3:25 PM EDT
Tiny nanoparticle could have big impact on patients receiving corneal transplants
Virginia Commonwealth University (VCU)

Corneal transplants can be the last step to returning clear vision to many patients suffering from eye disease. Each year, approximately 80,000 corneal transplantations take place in the U.S. Worldwide, more than 184,000 corneal transplantation surgeries are performed annually.

   
Released: 24-Mar-2023 12:10 PM EDT
Buprenorphine After Nonfatal Opioid Overdose Results in Reduced Risk of Overdose Death
Rutgers University-New Brunswick

Receiving medication for opioid use disorders, such as buprenorphine after an overdose, leads to lower mortality risk, according to a Rutgers study.

Newswise: A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapy
Released: 24-Mar-2023 12:05 AM EDT
A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapy
University of California, Los Angeles (UCLA), Health Sciences

MitoQ, a mitochondrial antioxidant that is available to the public as a diet supplement, was found in a mouse study to reverse the detrimental effects that HIV and antiretroviral therapy (ART) have on mitochondria in the brain, heart, aorta, lungs, kidney and liver.

Released: 23-Mar-2023 11:05 AM EDT
Big Data and AI Meet Cancer Research
University of New Mexico Comprehensive Cancer Center

Avinash Sahu, PhD, and his team leveraged artificial intelligence, machine learning, and big data to create a novel way to discover multi-function drugs. The approach used cancer research data, biological data, and transfer learning to not only find drugs with specific properties but also to predict patient responses to them.

   
17-Mar-2023 11:05 AM EDT
In Epilepsy, Higher Risk of Early Death Varies Based on Severity, Other Factors
American Academy of Neurology (AAN)

A new study has found that people with epilepsy have an increased risk of early death and the increased risk varies depending on where they live, the number of medications they take and what other diseases they may have. The study is published in the March 22, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Study: Spice May Improve Ovarian Cancer Treatment
Released: 22-Mar-2023 3:45 PM EDT
Study: Spice May Improve Ovarian Cancer Treatment
New York Institute of Technology, New York Tech

New research makes the case for why curcumin could help enhance treatment for ovarian cancer.

   
Released: 22-Mar-2023 11:25 AM EDT
Seniors’ use of urinary-tract infection antibiotics halved
University of Gothenburg

As an international study involving University of Gothenburg researchers has shown, a decision tool for health professionals has proved capable of halving the use of antibiotics against urinary tract infections while maintaining patient safety.

Newswise: Scientists use tardigrade proteins for human health breakthrough
Released: 20-Mar-2023 7:00 PM EDT
Scientists use tardigrade proteins for human health breakthrough
University of Wyoming

University of Wyoming researchers’ study of how microscopic creatures called tardigrades survive extreme conditions has led to a major breakthrough that could eventually make life-saving treatments available to people where refrigeration isn’t possible.

Released: 20-Mar-2023 6:35 PM EDT
Advanced brain imaging study hints at how DMT psychedelic alters perception of reality
Imperial College London

In a study at Imperial College London, detailed brain imaging data from 20 healthy volunteers revealed how the potent psychedelic compound, DMT (dimethyltryptamine), alters brain function.

Not for public release

This news release is embargoed until 20-Mar-2023 5:00 PM EDT Released to reporters: 14-Mar-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 20-Mar-2023 4:15 PM EDT Released to reporters: 27-Jul-2022 1:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2023 4:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

       
Released: 20-Mar-2023 9:00 AM EDT
Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel.
Newswise

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

     
Released: 17-Mar-2023 2:25 PM EDT
The new insulin price cap: What you need to know
Michigan Medicine - University of Michigan

In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly’s move.

Newswise: A New Combination Therapy Regimen Shows Promising Results for Prostate Cancer
Released: 16-Mar-2023 4:35 PM EDT
A New Combination Therapy Regimen Shows Promising Results for Prostate Cancer
University of Utah Health

The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo, the investigatory combination of TALZENNA and XTANDI demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival.

Newswise: DNA Treatment Could Delay Paralysis That Strikes Nearly All Patients With ALS
Released: 16-Mar-2023 2:30 PM EDT
DNA Treatment Could Delay Paralysis That Strikes Nearly All Patients With ALS
University of California San Diego

UC San Diego researchers use a DNA designer drug to restore key protein levels in motor neurons, delaying paralysis in a mouse model of ALS.

Released: 16-Mar-2023 9:00 AM EDT
Ochsner Health Advances Precision Medicine, Becomes National Leader in Universal Genomic Testing for Chemotherapy
Ochsner Health

Ochsner Health is leading the way for precision medicine nationwide by becoming one of the first hospital systems to standardize genomic testing, significantly advancing ways in which care teams can treat cancer patients. This change helps providers determine individualized treatment by understanding how patients will react to certain drugs, thereby lowering risk of adverse side effects, improving patient experience, and bettering patient outcomes.

Newswise: Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones
Released: 16-Mar-2023 12:05 AM EDT
Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones
University of South Australia

A large study of women with rheumatoid arthritis has found that those taking oral contraceptives or hormone replacement therapy (HRT) had a greater chance of achieving remission.

Released: 15-Mar-2023 1:30 PM EDT
Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease
Aitia

UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI and "Digital Twins" to discover and develop new drugs, today announced an early drug discovery collaboration focused on the discovery and validation of novel drug targets and drug candidates for Huntington's disease.

Newswise: Antidepressant Medication May Be Key to Help People Stop Use of Cocaine While in Treatment for Opioid Use Disorder
Released: 15-Mar-2023 12:05 PM EDT
Antidepressant Medication May Be Key to Help People Stop Use of Cocaine While in Treatment for Opioid Use Disorder
Johns Hopkins Medicine

For some people receiving methadone for treatment of opioid use disorder (OUD), the co-use of opioids and stimulants such as cocaine is an issue. Now, a new study led by Johns Hopkins Medicine researchers found that bupropion, an antidepressant medication also used for smoking cessation, may help people stop using cocaine while in treatment for OUD.

14-Mar-2023 12:00 PM EDT
Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center showed that inhibiting menin with revumenib, previously known as SNDX-5613, yielded encouraging responses for advanced acute leukemias with KMT2A rearrangements or mutant NPM1. Findings from the Phase I AUGMENT-101 trial were published today in Nature.

Released: 14-Mar-2023 2:25 PM EDT
Potential Treatment Target for Drug-Resistant Epilepsy Identified
Tufts University

A new study by Tufts University researchers found a molecule that could be a target for treatment in patients who have become resistant to traditional anti-seizure drugs

   
Released: 14-Mar-2023 7:00 AM EDT
Diuretics Work Differently According to Biological Sex and Time of Treatment
American Physiological Society (APS)

A new computational study in a mouse model finds biological sex and time of day makes a difference in the effectiveness of diuretics—medications commonly prescribed to manage high blood pressure. The study is published ahead of print in the American Journal of Physiology-Renal Physiology.

Released: 14-Mar-2023 6:05 AM EDT
Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed
Perelman School of Medicine at the University of Pennsylvania

Up to 50 percent of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Nature Communications, suggest there may be new opportunities to treat cancer with new or existing drugs.

Newswise: Mountainside Medical Center Recognized for Antimicrobial Stewardship
Released: 13-Mar-2023 9:00 AM EDT
Mountainside Medical Center Recognized for Antimicrobial Stewardship
Hackensack Meridian Health (Mountainside Medical Center)

Hackensack Meridian Mountainside Medical Center has been recognized as a Silver Level Antimicrobial Stewardship Recognition Program award recipient by the NJDOH.

Newswise: New Class of Drugs Could Prevent Resistant COVID-19 Variants
Released: 10-Mar-2023 6:00 PM EST
New Class of Drugs Could Prevent Resistant COVID-19 Variants
Yale Cancer Center/Smilow Cancer Hospital

The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered that a new class of oral drugs that acts directly on human cells can inhibit a diverse range of pathogenic SARS-CoV-2 strains. In their newly published study, the team found a novel mechanism through which the gene that expresses angiotensin converting enzyme-2 (ACE-2)—the cellular receptor to which SARS-CoV-2 binds so that it can enter and infect the cell—is turned on.

Released: 10-Mar-2023 12:15 PM EST
Prenatal exposure to anti-nausea drug in ‘60s, ‘70s tied to increased risk of colorectal cancer
University of Texas Health Science Center at Houston

Prenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase risk of colorectal cancer in adult offspring, according to a study by researchers at UTHealth Houston.

Released: 9-Mar-2023 2:45 PM EST
Reducing opioids prescribed after total knee and hip arthroplasty can be beneficial for patients and doctors
Michigan Medicine - University of Michigan

Opioids are commonly prescribed to patients that are discharged after a total knee and hip arthroplasty. Patients are typically given larger prescriptions of opioids that can result in an excess of the medication in their home after recovery is over.

Released: 9-Mar-2023 11:55 AM EST
Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2023 Annual Meeting
Stuart Therapeutics

Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that it is sponsoring two research poster presentations by researchers at Vanderbilt University and the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which will take place from April 23-27, 2023, in New Orleans, Louisiana.

   
Newswise: New Class of Drugs May Prevent Infection by Wide Range of COVID-19 Variants
Released: 9-Mar-2023 11:05 AM EST
New Class of Drugs May Prevent Infection by Wide Range of COVID-19 Variants
Dana-Farber Cancer Institute

A new class of oral drugs can inhibit a wide range of SARS-CoV-2 variants, researchers report, potentially identifying new antiviral agents providing broad activity against the constantly emerging new strains of the COVID-19 virus

9-Mar-2023 10:00 AM EST
HSS Presents Research at 2023 AAOS Annual Meeting
Hospital for Special Surgery

At this year’s American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, held March 7 to 11 in Las Vegas, Hospital for Special Surgery (HSS) presented new research on a variety of topics in orthopedic surgery, including studies related to minimally invasive surgery, racial disparities, and opioid alternatives for pain management in spine care.

Released: 8-Mar-2023 12:40 PM EST
New Study: Abatacept Therapy Offers Promising Results Treating Juvenile Dermatomyositis
George Washington University

Juvenile dermatomyositis, a rare but often severe and chronic systemic autoimmune disease, includes a large number of patients who are treatment resistant, requiring long term immunosuppressive therapy. A small open-label study published in Arthritis and Rheumatology shows promise using a targeted biologic therapy called abatacept to treat such patients.



close
2.6818